HGH Holdings Statistics

Total Valuation

HGH Holdings has a market cap or net worth of SGD 26.71 million. The enterprise value is 29.97 million.

Market Cap	26.71M
Enterprise Value	29.97M

Important Dates

The next estimated earnings date is Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

HGH Holdings has 1.78 billion shares outstanding. The number of shares has decreased by -29.81% in one year.

Current Share Class	n/a
Shares Outstanding	1.78B
Shares Change (YoY)	-29.81%
Shares Change (QoQ)	-66.88%
Owned by Insiders (%)	59.99%
Owned by Institutions (%)	9.77%
Float	712.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.88
PB Ratio	0.58
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.89, with an EV/FCF ratio of -9.41.

EV / Earnings	-239.79
EV / Sales	1.41
EV / EBITDA	7.89
EV / EBIT	n/a
EV / FCF	-9.41

Financial Position

The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.17.

Current Ratio	1.55
Quick Ratio	1.34
Debt / Equity	0.17
Debt / EBITDA	2.08
Debt / FCF	-2.48
Interest Coverage	-0.85

Financial Efficiency

Return on equity (ROE) is -0.33% and return on invested capital (ROIC) is -0.28%.

Return on Equity (ROE)	-0.33%
Return on Assets (ROA)	-0.22%
Return on Invested Capital (ROIC)	-0.28%
Return on Capital Employed (ROCE)	-0.39%
Revenue Per Employee	98,713
Profits Per Employee	-579
Employee Count	216
Asset Turnover	0.32
Inventory Turnover	59.73

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.36% in the last 52 weeks. The beta is 0.05, so HGH Holdings's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	+36.36%
50-Day Moving Average	0.02
200-Day Moving Average	0.01
Relative Strength Index (RSI)	43.65
Average Volume (20 Days)	1,034,625

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HGH Holdings had revenue of SGD 21.32 million and -125,000 in losses. Loss per share was -0.00.

Revenue	21.32M
Gross Profit	6.11M
Operating Income	-235,000
Pretax Income	-251,000
Net Income	-125,000
EBITDA	3.42M
EBIT	-235,000
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 4.55 million in cash and 7.91 million in debt, giving a net cash position of -3.36 million or -0.00 per share.

Cash & Cash Equivalents	4.55M
Total Debt	7.91M
Net Cash	-3.36M
Net Cash Per Share	-0.00
Equity (Book Value)	45.99M
Book Value Per Share	0.03
Working Capital	4.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.58 million and capital expenditures -5.77 million, giving a free cash flow of -3.19 million.

Operating Cash Flow	2.58M
Capital Expenditures	-5.77M
Free Cash Flow	-3.19M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 28.64%, with operating and profit margins of -1.10% and -0.59%.

Gross Margin	28.64%
Operating Margin	-1.10%
Pretax Margin	-1.18%
Profit Margin	-0.59%
EBITDA Margin	16.02%
EBIT Margin	-1.10%
FCF Margin	n/a

Dividends & Yields

HGH Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	29.81%
Shareholder Yield	29.81%
Earnings Yield	-0.47%
FCF Yield	-11.93%

Stock Splits

The last stock split was on November 25, 2016. It was a forward split with a ratio of 5.359056806.

Last Split Date	Nov 25, 2016
Split Type	Forward
Split Ratio	5.359056806

Scores

HGH Holdings has an Altman Z-Score of 1.35. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.35
Piotroski F-Score	n/a